The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
Open accessAbstract
Only a fraction of cancer patients benefits from immune checkpoint inhibitors. This may be partly due to the dense extracellular matrix (ECM) that forms a barrier for T cells. Comparing five preclinical mouse tumor models with heterogeneous tumor microenvironments, we aimed to relate the rate of tumor stiffening with the remodeling of ECM architecture and to determine how these features affect intratumoral T cell migration. An ECM-targeted strategy, based on the inhibition of lysyl oxidase, was used. In vivo stiffness measurements were found to be strongly correlated with tumor growth and ECM crosslinking but negatively correlated with T cell migration. Interfering with collagen stabilization reduces ECM content and tumor stiffness leading to improved T cell migration and increased efficacy of anti-PD-1 blockade. This study highlights the rationale of mechanical characterizations in solid tumors to understand resistance to immunotherapy and of combining treatment strategies targeting the ECM with anti-PD-1 therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
T cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Mechanotransduction and extracellular matrix homeostasis
Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,124
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Wolf, K., te Lindert, M., Krause, M., Alexander, S., te Riet, J., Willis, A. L., Hoffman, R. M., Figdor, C. G., Weiss, S. J., & Friedl, P. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210152 · Cited by 1,375
QUANTITATIVE OPTICAL SPECTROSCOPY FOR TISSUE DIAGNOSIS
Richards-Kortum, R., & Sevick-Muraca, E. (1996) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.47.1.555 · Cited by 1,172
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M.-C., Validire, P., Trautmann, A., Mami-Chouaib, F., & Donnadieu, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45817 · Cited by 1,138
Self-citationLin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
The nanomechanical signature of breast cancer
Plodinec, M., Loparic, M., Monnier, C. A., Obermann, E. C., Zanetti-Dallenbach, R., Oertle, P., Hyotyla, J. T., Aebi, U., Bentires-Alj, M., Lim, R. Y. H., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.167 · Cited by 1,102
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Jiang, H., Hegde, S., Knolhoff, B. L., Zhu, Y., Herndon, J. M., Meyer, M. A., Nywening, T. M., Hawkins, W. G., Shapiro, I. M., Weaver, D. T., et al. (2016) · Nature Medicine · doi:10.1038/nm.4123 · Cited by 1,060
Hegde, P. S., Karanikas, V., & Evers, S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1507 · Cited by 1,000
Krebs, A. M., Mitschke, J., Lasierra Losada, M., Schmalhofer, O., Boerries, M., Busch, H., Boettcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 975
Peranzoni, E., Lemoine, J., Vimeux, L., Feuillet, V., Barrin, S., Kantari-Mimoun, C., Bercovici, N., Guérin, M., Biton, J., Ouakrim, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720948115 · Cited by 919
Self-citationDynamic interplay between the collagen scaffold and tumor evolution
Egeblad, M., Rasch, M. G., & Weaver, V. M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.015 · Cited by 896
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Caruana, I., Savoldo, B., Hoyos, V., Weber, G., Liu, H., Kim, E. S., Ittmann, M. M., Marchetti, D., & Dotti, G. (2015) · Nature Medicine · doi:10.1038/nm.3833 · Cited by 814
Samani, A., Zubovits, J., & Plewes, D. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/6/002 · Cited by 707
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Anderson, K. G., Stromnes, I. M., & Greenberg, P. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.008 · Cited by 702
Carstens, J. L., Correa de Sampaio, P., Yang, D., Barua, S., Wang, H., Rao, A., Allison, J. P., LeBleu, V. S., & Kalluri, R. (2017) · Nature Communications · doi:10.1038/ncomms15095 · Cited by 633
Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Lampi, M. C., & Reinhart-King, C. A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0475 · Cited by 551
Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & del Río Hernández, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 523
Targeting T Cell Co-receptors for Cancer Therapy
Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.023 · Cited by 469
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines
Peng, W., Liu, C., Xu, C., Lou, Y., Chen, J., Yang, Y., Yagita, H., Overwijk, W. W., Lizée, G., Radvanyi, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1187 · Cited by 432
Kaur, A., Ecker, B. L., Douglass, S. M., Kugel, C. H., Webster, M. R., Almeida, F. V., Somasundaram, R., Hayden, J., Ban, E., Ahmadzadeh, H., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0193 · Cited by 418
Matrix stiffening promotes a tumor vasculature phenotype
Bordeleau, F., Mason, B. N., Lollis, E. M., Mazzola, M., Zanotelli, M. R., Somasegar, S., Califano, J. P., Montague, C., LaValley, D. J., Huynh, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613855114 · Cited by 416
Bredfeldt, J. S., Liu, Y., Pehlke, C. A., Conklin, M. W., Szulczewski, J. M., Inman, D. R., Keely, P. J., Nowak, R. D., Mackie, T. R., & Eliceiri, K. W. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.1.016007 · Cited by 412
Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815515116 · Cited by 406
High response rate to PD-1 blockade in desmoplastic melanomas
Eroglu, Z., Zaretsky, J. M., Hu-Lieskovan, S., Kim, D. W., Algazi, A., Johnson, D. B., Liniker, E., Kong, B., Munhoz, R., Rapisuwon, S., et al. (2018) · Nature · doi:10.1038/nature25187 · Cited by 338
Job, S., Rapoud, D., Dos Santos, A., Gonzalez, P., Desterke, C., Pascal, G., Elarouci, N., Ayadi, M., Adam, R., Azoulay, D., et al. (2020) · Hepatology · doi:10.1002/hep.31092 · Cited by 322
MR Elastography of Liver Tumors: Preliminary Results
Venkatesh, S. K., Yin, M., Glockner, J. F., Takahashi, N., Araoz, P. A., Talwalkar, J. A., & Ehman, R. L. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3123 · Cited by 312
Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 298
Miller, B. W., Morton, J. P., Pinese, M., Saturno, G., Jamieson, N. B., McGhee, E., Timpson, P., Leach, J., McGarry, L., Shanks, E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404827 · Cited by 286
Yamauchi, M., Barker, T. H., Gibbons, D. L., & Kurie, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93554 · Cited by 270
Evans, A., Whelehan, P., Thomson, K., McLean, D., Brauer, K., Purdie, C., Baker, L., Jordan, L., Rauchhaus, P., & Thompson, A. (2012) · Radiology · doi:10.1148/radiol.12111317 · Cited by 268
Method for Picrosirius Red-Polarization Detection of Collagen Fibers in Tissue Sections
Rittié, L. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7113-8_26 · Cited by 249
The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy
Miller, J. F. A. P., & Sadelain, M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.007 · Cited by 245
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Jiang, H., Hegde, S., & DeNardo, D. G. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2003-1 · Cited by 242
Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
PAPAGEORGIS, P., & STYLIANOPOULOS, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 206
Borowsky, A. D., Namba, R., Young, L. J. T., Hunter, K. W., Hodgson, J. G., Tepper, C. G., McGoldrick, E. T., Muller, W. J., Cardiff, R. D., & Gregg, J. P. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2908-5 · Cited by 194
Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis
Cox, T. R., Gartland, A., & Erler, J. T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2306 · Cited by 174
Elahi-Gedwillo, K. Y., Carlson, M., Zettervall, J., & Provenzano, P. P. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1334 · Cited by 167
Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis
Baker, A., Bird, D., Welti, J. C., Gourlaouen, M., Lang, G., Murray, G. I., Reynolds, A. R., Cox, T. R., & Erler, J. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2447 · Cited by 166
Bougherara, H., Mansuet‐Lupo, A., Alifano, M., Ngô, C., Damotte, D., Frère‐Belda, M. L., Donnadieu, E., & Peranzoni, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00500 · Cited by 162
Self-citationIncio, J., Suboj, P., Chin, S. M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I. X., Deshpande, V., Jain, R. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141392 · Cited by 153
Depth-sensing analysis of cytoskeleton organization based on AFM data
Pogoda, K., Jaczewska, J., Wiltowska-Zuber, J., Klymenko, O., Zuber, K., Fornal, M., & Lekka, M. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0761-9 · Cited by 143
Self-citationGilles, M.-E., Maione, F., Cossutta, M., Carpentier, G., Caruana, L., Maria, S. D., Houppe, C., Destouches, D., Shchors, K., Prochasson, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0300 · Cited by 143
Self-citationInfiltration of CD8 + T cells into tumor cell clusters in triple-negative breast cancer
Li, X., Gruosso, T., Zuo, D., Ömeroğlu, A., Meterissian, S. H., Guiot, M., Salazar, A., Park, M., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817652116 · Cited by 143
Tumor Elastography and Its Association with Collagen and the Tumor Microenvironment
Riegler, J., Labyed, Y., Rosenzweig, S. J., Javinal, V., Castiglioni, A., Dominguez, C. X., Long, J. E., Li, Q., Sandoval, W. N., Junttila, M. R., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3262 · Cited by 133
Positive and negative influence of the matrix architecture on antitumor immune surveillance
Peranzoni, E., Rivas-Caicedo, A., Bougherara, H., Salmon, H., & Donnadieu, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1339-8 · Cited by 117
Self-citationMarturano, J. E., Xylas, J. F., Sridharan, G. V., Georgakoudi, I., & Kuo, C. K. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.11.024 · Cited by 110
Marangon, I., Silva, A., Guilbert, T., Kolosnjaj‐Tabi, J., Marchiol, C., Natkhunarajah, S., Chammings, F., Ménard‐Moyon, C., Bianco, A., Gennisson, J., et al. (2016) · Theranostics · doi:10.7150/thno.17574 · Cited by 97
Self-citationTaylor, M. A., Amin, J., Kirschmann, D. A., & Schiemann, W. P. (2011) · Neoplasia · doi:10.1593/neo.101086 · Cited by 96
Zaffryar‐Eilot, S., Marshall, D. C. L., Voloshin, T., Bar‐Zion, A., Spangler, R. H., Kessler, O., Ghermazien, H., Brekhman, V., Suss-Toby, E., Adam, D., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt241 · Cited by 94
Mieulet, V., Garnier, C., Kieffer, Y., Guilbert, T., Nemati, F., Marangoni, E., Renault, G., Chamming’s, F., Vincent-Salomon, A., & Mechta-Grigoriou, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-83685-0 · Cited by 79
Self-citationTGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Guérin, M. V., Régnier, F., Feuillet, V., Vimeux, L., Weiss, J. M., Bismuth, G., Altan-Bonnet, G. Y., Guilbert, T., Thoreau, M., Finisguerra, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11998-w · Cited by 77
Self-citationMatrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
Deligne, C., Murdamoothoo, D., Gammage, A. N., Gschwandtner, M., Erne, W., Loustau, T., Marzeda, A. M., Carapito, R., Paul, N., Velázquez-Quesada, I., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0276 · Cited by 70
Nilsson, M., Adamo, H. H., Bergh, A. R. J., & Bergström, S. H. (2016) · Scientific Reports · doi:10.1038/srep19608 · Cited by 68
Yoo, J., Seo, B. K., Park, E. K., Kwon, M., Jeong, H., Cho, K. R., Woo, O. H., Song, S. E., & Cha, J. (2020) · Cancer Imaging · doi:10.1186/s40644-020-00362-7 · Cited by 67
Datar, I. J., & Schalper, K. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0336 · Cited by 56
Evans, A. J., Sim, Y. T., Pourreyron, C., Thompson, A., Jordan, L. B., Fleming, D., Purdie, C. A., Macaskill, J., Vinnicombe, S., & Pharoah, P. D. P. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4836-5 · Cited by 34
Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy
Peranzoni, E., Bougherara, H., Ghamry-Barrin, S., Mansuet‐Lupo, A., Alifano, M., Damotte, D., & Donnadieu, E. (2017) · Journal of Visualized Experiments · doi:10.3791/55709 · Cited by 30
Self-citationReduced CTL motility and activity in avascular tumor areas
Manaster, Y., Shipony, Z., Hutzler, A., Kolesnikov, M., Avivi, C., Shalmon, B., Barshack, I., Besser, M. J., Feferman, T., & Shakhar, G. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02361-5 · Cited by 30
Chen, I. X., Chauhan, V. P., Posada, J. M., Ng, M. R., Wu, M., Adstamongkonkul, P., Huang, P., Lindeman, N. I., Langer, R., & Jain, R. K. (2019) · Tumor Biology · doi:10.1158/1538-7445.sabcs18-2744 · Cited by 6
Cited by
Immune Checkpoint Inhibitors in Cancer Therapy
Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022) · Current Oncology · doi:10.3390/curroncol29050247 · Cited by 1,353
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
The extracellular matrix and the immune system: A mutually dependent relationship
Sutherland, T. E., Dyer, D. P., & Allen, J. E. (2023) · Science · doi:10.1126/science.abp8964 · Cited by 519
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Jiang, Y., Zhang, H., Wang, J., Liu, Y., Luo, T., & Hua, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01252-0 · Cited by 491
Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy
Mai, Z., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06697-4 · Cited by 398
Metadata
- Authors
- Nicolas-Boluda, A., Vaquero, J., Vimeux, L., Guilbert, T., Barrin, S., Kantari-Mimoun, C., Ponzo, M., Renault, G., Deptula, P., Pogoda, K., Bucki, R., Cascone, I., Courty, J., Fouassier, L., Gazeau, F., & Donnadieu, E.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-06-09
- Volume
- 10
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W3168119119
- Cited by
- 368
- References
- 71
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.